Search Results 491-500 of 16068 for pharmacogenetics
The long term research goal and objective of this application is to improve the clinical outcomes of patients with biliary tract cancers and germ cell tumors.
About this study · characterize their risk for developing T1D and identify subjects eligible for prevention trials; · describe the pathogenic evolution of T1D; ...
Share · Tweet. See also. Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain ...
Shahi M, Katsakhyan L, Hopkins M, Allen-Rhoades W, Cepress MK, Langstraat C, Ishitani MB, Vang R, Ronnett BM, Xing D. Ovarian non-gestational placental site ...
Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...
About this study. The purpose of this study evaluates a subset of people with isolated Impaired Fasting Glucose with Normal Glucose Tolerance (i.e., ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
The Pharmacology Shared Resource provides preclinical and clinical pharmacokinetic, pharmacodynamic and pharmacogenetic expertise, methodologies and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to determine the effects of increased free fatty acid concentrations in blood plasma, on the metabolism of muscle proteins.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.